PH4S014 - Medicines: Scale-up, Formulation, and Manufacture 01 Apr 2025 - 31 Aug 2027 | Version 3
Associated Module Information
| Module Code: | PH4S014 | ||
|---|---|---|---|
| Module Title: | Medicines: Scale-up, Formulation, and Manufacture | ||
| Faculty: | Faculty of Computing, Engineering and Science | ||
| Faculty Group: | Chemical and Environmental Sciences | ||
| Faculty Sub Group: | Chemical and Environmental Sciences | ||
| Module Leader: | Andrew Graham | ||
| Module Team: | Suzanna Kean, Natasha Galea | ||
| First Intended Intake: | SEP 2018 | Final Year of Intake: | |
| Date Closed: | |||
| Credit Value: | 20 | Credit Level: | 7 |
| Language: | English | ||
| Percentage of Module Taught in Welsh: | 0 | ||
| Equivalent Module: | |||
| HECOS codes: | 100251 - pharmacy | ||
| HECOS Code Weighting: | 100 | ||
Document Version Information
| Version | 3 |
|---|---|
| Valid From | 01 Apr 2025 |
| Valid To | 31 Aug 2027 |
Module Aims
To impart an appreciation of the practical difficulties in taking discoveries/syntheses from the laboratory scale to the bulk scale (scale up) and enable students to provide possible solutions to challenging scenarios.
To introduce basic formulations.
To consider and design a simple route of manufacture.
Content Summary
This module will challenge students to think about the factors that need to be considered when working in the area of process development/laboratory scale, to identify potential hazards or processes that would prove challenging to perform on a bulk scale and provide alternative pathways..
Upon having access to chemicals in bulk, the module then looks at the principles of preformulation science and simple single phase formulations (liquids/solutions and the solid phase). Topics covered include such things as pharmaceuticals and medicines, pharmaceutical solutions, pH, solubility, the factors that affect the ability of the drug to still retain its activity yet be deliverable to its target organ/cell, the pharmaceutical solid phase i.e. crystal polymorphism of pharmaceuticals and solid-state properties of powder particles.
The final part of the module then looks at the manufacture of tablets and simple solutions/syrups (i.e., the large scale manufacture of formulations). Topics covered will include the process flow, the machines involved and their function, and other considerations surrounding the design of, and key points in, the production line.
Whenever possible a site visits will be organised to complement this module.
Learning and Teaching Methods
| Activity Type | Hours |
|---|---|
| Lecture | 18 |
| Tutorial | 18 |
| Independent Study | 64 |
| Directed Study | 100 |
| Formative Assessment - Independent | 2 |
| Practical Classes and Workshops | 16 |
| Total Hours Selected | 218 |
Learning Outcomes
| # | Learning Outcome |
|---|---|
| LO1 | To critically evaluate the practical difficulties in taking discoveries from the laboratory scale to the bulk scale (scale up for both syntheses and manufacture). |
| LO2 | Critically evaluate the physicochemical properties of pharmaceutics for preformulation and formulation of medicines and demonstrate understanding of factors such as solubility, pH, polymorphism and particle size and their influence on bioavailability. |
Module Requisites
N/A
Assessment Criteria
| Assessment Category | Assessment Type | Description | Duration | Word Count | Weight (%) | Best of? | Pass Mark |
|---|---|---|---|---|---|---|---|
| Asynchronous Assessment | Report 1 | Written assignment allowing demonstration of application of the taught theory of the module. | 0 | 2000 | 50 | No | 40 |
| Synchronous Onsite Practical Assessment | Practical Coursework (Onsite) 1 | A? guided assessment allowing students to evidence the application and development of practical skills and problem solving over a series of practical sessions. | 0 | 2000 | 50 | No | 40 |
Assessment Matrix
| Assessment Type | Learning Outcomes | ||
|---|---|---|---|
| LO1 | LO2 | ||
| Report 1 | ✔ | ✔ | |
| Practical Coursework (Onsite) 1 | ✔ | ✔ | |